Related Experiment Video
Updated: Mar 16, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.8K
Inherited platelet function disorders. Diagnostic approach and management.
Paolo Gresele1, Emanuela Falcinelli, Loredana Bury
1Paolo Gresele, MD, PhD, Division of Internal and Cardiovascular Medicine Department of Medicine, University of Perugia, Via E. dal Pozzo, 06126 Perugia, Italy, Tel. +39/07 55 78 39 89, Fax +39/07 55 71 60 83,
Hamostaseologie
|August 4, 2016
Summary
Diagnosing inherited platelet function disorders (IPFDs) requires a structured approach. This review details diagnostic methods, management strategies, and bleeding risks for these rare bleeding conditions.
Area of Science:
- Hematology
- Clinical diagnostics
- Genetics
Background:
- Inherited platelet function disorders (IPFDs) are a significant cause of congenital bleeding disorders.
- These conditions are often poorly understood and challenging to diagnose accurately.
- A standardized diagnostic pathway is essential for effective management.
Purpose of the Study:
- To outline a rational diagnostic strategy for IPFDs.
- To review current approaches for managing bleeding in patients with IPFDs.
- To summarize data on bleeding risks during invasive procedures.
Main Methods:
- Discusses a diagnostic approach integrating platelet phenotyping and genotyping.
- Reviews literature on bleeding management options for IPFDs.
- Analyzes existing studies on procedural bleeding risks and treatments.
Main Results:
- A systematic diagnostic sequence aids in identifying various IPFDs.
- Phenotyping and genotyping offer comprehensive diagnostic capabilities.
- Evidence on bleeding risk and management for invasive procedures is limited but informative.
Conclusions:
- A stepwise diagnostic approach is crucial for diagnosing IPFDs.
- Integrated phenotyping and genotyping improve diagnostic accuracy.
- Further research is needed to fully characterize bleeding risks and optimize management strategies.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:24Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
01:18Structure and Function of Platelets
4.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
01:22Formation of the Platelet Plug
10.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.4K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
01:29Venous Thrombosis III: Interprofessional Care
453
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453